Results of a Multicenter, Randomized, Double-Blind, Phase III Study of TAS-102 vs. Placebo, with Best Supportive Care (BSC), in Patients (PTS) with Metastatic Colorectal Cancer (MCRC) Refractory to Standard Therapies (RECOURSE)

on behalf of the RECOURSE Study Group

doi:10.1093/annonc/mdu193.22

Results of a Multicenter, Randomized, Double-Blind, Phase III Study of TAS-102 vs. Placebo, with Best Supportive Care (BSC), in Patients (PTS) with Metastatic Colorectal Cancer (MCRC) Refractory to Standard Therapies (RECOURSE)

on behalf of the RECOURSE Study Group

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	ii114
Journal	Annals of Oncology
Volume	25
DOIs	https://doi.org/10.1093/annonc/mdu193.22
Publication status	Published - Jun 2014

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdu193.22

Cite this

Results of a Multicenter, Randomized, Double-Blind, Phase III Study of TAS-102 vs. Placebo, with Best Supportive Care (BSC), in Patients (PTS) with Metastatic Colorectal Cancer (MCRC) Refractory to Standard Therapies (RECOURSE). / on behalf of the RECOURSE Study Group.

In: Annals of Oncology, Vol. 25, 06.2014, p. ii114.

Research output: Contribution to journal › Article › peer-review

@article{177baea3882d452d9cc9c92f8d85bf9d,

title = "Results of a Multicenter, Randomized, Double-Blind, Phase III Study of TAS-102 vs. Placebo, with Best Supportive Care (BSC), in Patients (PTS) with Metastatic Colorectal Cancer (MCRC) Refractory to Standard Therapies (RECOURSE)",

author = "{on behalf of the RECOURSE Study Group} and T. Yoshino and R. Mayer and A. Falcone and A. Ohtsu and R. Garcia-Carbonero and N. Mizunuma and K. Yamazaki and Y. Shimada and J. Tabernero and Y. Komatsu and A. Sobrero and E. Boucher and M. Peeters and B. Tran and Lenz, {H. J.} and A. Zaniboni and H. Hochster and F. Benedetti and M. Aivado and L. Makris and M. Ito and {Van Cutsem}, E.",

year = "2014",

month = jun,

doi = "10.1093/annonc/mdu193.22",

language = "English",

volume = "25",

pages = "ii114",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "NLM (Medline)",

}

TY - JOUR

T1 - Results of a Multicenter, Randomized, Double-Blind, Phase III Study of TAS-102 vs. Placebo, with Best Supportive Care (BSC), in Patients (PTS) with Metastatic Colorectal Cancer (MCRC) Refractory to Standard Therapies (RECOURSE)

AU - on behalf of the RECOURSE Study Group

AU - Yoshino, T.

AU - Mayer, R.

AU - Falcone, A.

AU - Ohtsu, A.

AU - Garcia-Carbonero, R.

AU - Mizunuma, N.

AU - Yamazaki, K.

AU - Shimada, Y.

AU - Tabernero, J.

AU - Komatsu, Y.

AU - Sobrero, A.

AU - Boucher, E.

AU - Peeters, M.

AU - Tran, B.

AU - Lenz, H. J.

AU - Zaniboni, A.

AU - Hochster, H.

AU - Benedetti, F.

AU - Aivado, M.

AU - Makris, L.

AU - Ito, M.

AU - Van Cutsem, E.

PY - 2014/6

Y1 - 2014/6

UR - http://www.scopus.com/inward/record.url?scp=85081976858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081976858&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdu193.22

DO - 10.1093/annonc/mdu193.22

M3 - Article

SN - 0923-7534

VL - 25

SP - ii114

JO - Annals of Oncology

JF - Annals of Oncology

ER -

Results of a Multicenter, Randomized, Double-Blind, Phase III Study of TAS-102 vs. Placebo, with Best Supportive Care (BSC), in Patients (PTS) with Metastatic Colorectal Cancer (MCRC) Refractory to Standard Therapies (RECOURSE)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this